3-(4-Bromophenyl)-5-((5-(3,5-difluorophenyl)-1,3,4-oxadiazol-2-yl)methyl)-1,2,4-oxadiazole结构式
|
常用名 | 3-(4-Bromophenyl)-5-((5-(3,5-difluorophenyl)-1,3,4-oxadiazol-2-yl)methyl)-1,2,4-oxadiazole | 英文名 | 3-(4-Bromophenyl)-5-((5-(3,5-difluorophenyl)-1,3,4-oxadiazol-2-yl)methyl)-1,2,4-oxadiazole |
|---|---|---|---|---|
| CAS号 | 1251616-16-6 | 分子量 | 419.2 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C17H9BrF2N4O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 3-(4-Bromophenyl)-5-((5-(3,5-difluorophenyl)-1,3,4-oxadiazol-2-yl)methyl)-1,2,4-oxadiazole |
|---|
| 分子式 | C17H9BrF2N4O2 |
|---|---|
| 分子量 | 419.2 |
| InChIKey | NFGGPWCOCYQJGH-UHFFFAOYSA-N |
| SMILES | Fc1cc(F)cc(-c2nnc(Cc3nc(-c4ccc(Br)cc4)no3)o2)c1 |
|
实验名称:Discovering small molecule activators of G protein-gated inwardly-rectifying potassiu...
来源:15621
靶标:G protein-activated inward rectifier potassium channel 2
External Id:VANDERBILT_HTS_GIRK2_MPD
|